Laura Gillund - Cardiovascular Systems Chief Talent Officer
| CSIIDelisted Stock | USD 20.00 0.00 0.00% |
Executive
Ms. Laura J. Gillund serves as Chief Talent Officer of the company. Ms. Gillund joined us in September 2013 as Vice President of Human Resources and Professional Development and was promoted to Chief Talent Officer in April 2016. Previously, Ms. Gillund was Vice President of Human Resources for C.H. Robinson Worldwide, Inc. from August 2002 to May 2012. Ms. Gillund serves as a member of the Board of Allina Health System and as member of the Board of Directors of College Possible. since 2013.
| Age | 56 |
| Tenure | 11 years |
| Phone | 651 259 1600 |
| Web | https://www.csi360.com |
Cardiovascular Systems Management Efficiency
The company has return on total asset (ROA) of (0.0756) % which means that it has lost $0.0756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1518) %, meaning that it created substantial loss on money invested by shareholders. Cardiovascular Systems' management efficiency ratios could be used to measure how well Cardiovascular Systems manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 22.15 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cardiovascular Systems has a current ratio of 5.93, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Cardiovascular Systems until it has trouble settling it off, either with new capital or with free cash flow. So, Cardiovascular Systems' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cardiovascular Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cardiovascular to invest in growth at high rates of return. When we think about Cardiovascular Systems' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jon Shear | Nevro Corp | N/A | |
| Brent JD | Bruker | 49 | |
| Suzanne Armstrong | Orthofix Medical | N/A | |
| Bryan Olin | LivaNova PLC | 57 | |
| Matthew Link | Sight Sciences | 49 | |
| Jeremy Livianu | Establishment Labs Holdings | 36 | |
| David Sandoval | MaxCyte | N/A | |
| Julie Dewey | Treace Medical Concepts | 63 | |
| Neeta Toprani | Establishment Labs Holdings | N/A | |
| Anthony Recupero | Si Bone | 65 | |
| Kristine Williams | Rapid Micro Biosystems | N/A | |
| Ronald CPA | MaxCyte | 66 | |
| Aimee Einstein | Si Bone | N/A | |
| Kashif Rashid | Nevro Corp | 50 | |
| Jay Gelfman | MaxCyte | N/A | |
| Peter Armstrong | Orthopediatrics Corp | 68 | |
| Shana MBA | Nevro Corp | N/A | |
| Chris Calcaterra | Glaukos Corp | 64 | |
| Irina Ridley | Neuropace | 38 | |
| CPA CFA | MaxCyte | 55 | |
| Stephen Deitsch | Paragon 28 | 52 | |
Management Performance
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 |
Cardiovascular Systems Leadership Team
Elected by the shareholders, the Cardiovascular Systems' board of directors comprises two types of representatives: Cardiovascular Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardiovascular. The board's role is to monitor Cardiovascular Systems' management team and ensure that shareholders' interests are well served. Cardiovascular Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardiovascular Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edward Brown, Independent Director | ||
| Stephen Rempe, Chief Officer | ||
| Jack Nielsen, Vice President Investor Relations & Corporate Communications | ||
| Peter Hirshman, VP Operations | ||
| Scott Ward, Chairman of the Board, Interim CEO and Presidentident | ||
| BSc MS, Pres Chairman | ||
| Alexander Rosenstein, General Counsel and Corporate Secretary | ||
| Jeffrey MD, Chief Officer | ||
| Laurence Betterley, CFO | ||
| Laura Gillund, Chief Talent Officer | ||
| John Nielsen, VP Communications | ||
| Scott Bartos, Independent Director | ||
| Sandra Sedo, Chief Compliance Officer | ||
| Rhonda Robb, COO | ||
| Jeffrey Points, Chief Officer | ||
| Leslie Trigg, Independent Director | ||
| William Cohn, Director | ||
| Brent Blackey, Independent Director | ||
| Philip Freed, VP Marketing | ||
| Augustine Lawlor, Independent Director | ||
| Paul Koehn, Sr. VP of Quality and Operations | ||
| Robert Thatcher, Chief Healthcare Policy Officer | ||
| Erik Paulsen, Independent Director | ||
| Kevin Kenny, COO | ||
| Martha Aronson, Independent Director |
Cardiovascular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardiovascular Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 466.13 M | |||
| Shares Outstanding | 42.2 M | |||
| Shares Owned By Insiders | 3.22 % | |||
| Shares Owned By Institutions | 89.64 % | |||
| Number Of Shares Shorted | 1.74 M | |||
| Price To Earning | 724.24 X |
Pair Trading with Cardiovascular Systems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardiovascular Systems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiovascular Systems will appreciate offsetting losses from the drop in the long position's value.Moving together with Cardiovascular Stock
| 0.69 | CVI | CVR Energy Financial Report 6th of May 2024 | PairCorr |
Moving against Cardiovascular Stock
| 0.76 | CSCO | Cisco Systems Fiscal Quarter End 30th of April 2024 | PairCorr |
| 0.44 | BA | Boeing Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Cardiovascular Systems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardiovascular Systems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardiovascular Systems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardiovascular Systems to buy it.
The correlation of Cardiovascular Systems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardiovascular Systems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardiovascular Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardiovascular Systems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |